Published in Medical Imaging Business Week, March 1st, 2007
Study 1: A report, "Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage," is newly published data in Journal of Neurosurgery. According to recent research from the United States, "OBJECT: Despite the application of current standard therapies, vasospasm continues to result in death or major disability in patients treated for ruptured aneurysms. The authors investigated the effectiveness of continous MgSO4 infusion for vasospasm prophylaxis."
"Seventy-six adults (mean age 54.6 years; 71% women; 92% Caucasian) were included in this comparative...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.